Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $4,636.5M | $4,178.0M | $3,433.1M | $5,275.0M | $4,128.0M | $1,774.0M | $5,144.0M | $5,953.0M | $5,309.0M | $5,687.0M | $7,882.0M | $4,616.0M | $11.5B | $11.8B | $4,863.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, AbbVie Inc.'s last 12-month Net Income is $5,122.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, AbbVie Inc.'s Net Income growth was (21.4%). The average annual Net Income growth rates for AbbVie Inc. have been (0.2%) over the past three years, 9.5% over the past five years.
Over the last year, AbbVie Inc.'s Net Income growth was (21.4%), which is lower than industry growth of (0.3%). It indicates that AbbVie Inc.'s Net Income growth is Bad.